AI-generated editorial illustration. It does not depict a documented real-world event.
What happened
Unitree Robotics began trading on the Shanghai Stock Exchange’s STAR Market on August 19, 2026, under ticker 688836. The exchange confirmed total A-share capital of approximately 404.46 million shares, with about 30.09 million shares available for trading from the listing date.
The company sold roughly 40.45 million new shares at RMB150.80 each and raised about RMB6.1 billion, equivalent to approximately US$904 million at the reported exchange rate. Investor demand then pushed the shares sharply higher. Associated Press reported that the stock opened as much as 629% above the offer price and closed at RMB845, a first-day gain of 460%.
That trading performance was a market event, not additional money raised by Unitree. The company received the IPO proceeds associated with the offering price; the higher closing price changed the market value assigned to its listed shares.
Confirmed facts
| Item | Confirmed detail |
|---|---|
| Listing date | August 19, 2026 |
| Exchange and ticker | Shanghai STAR Market, 688836 |
| New shares issued | Approximately 40.45 million |
| Offer price | RMB150.80 per share |
| Gross proceeds | Approximately RMB6.1 billion |
| First-day close | RMB845, reported as 460% above the offer price |
| Total post-listing shares | Approximately 404.46 million |
| Planned capital allocation | Model R&D, robot-body development, new products, and a manufacturing base |
The prospectus describes Unitree as a developer and manufacturer of humanoid robots, quadruped robots, components, and embodied-intelligence models. It also identifies research institutions, education, application development, industrial inspection, emergency response, performance, and intelligent services among the markets served by its products.
Company context
Unitree was founded in Hangzhou in 2016 and first became widely known for relatively accessible quadruped robots. It introduced its H1 humanoid in 2023 and later expanded the humanoid range with platforms including the G1. The company’s public filings show that its business mix changed rapidly as humanoid sales grew.
According to figures presented through the Shanghai Stock Exchange, Unitree reported RMB1.699 billion in 2025 revenue and RMB590 million in net profit excluding non-recurring items. Humanoid robots accounted for RMB868 million, or 51.78% of revenue, after contributing only 1.88% in 2023. The filing also says more than 5,500 humanoid robots were shipped in 2025. Shipment and market-ranking figures remain company disclosures even when reproduced in exchange materials.
More than 40% of 2025 revenue came from overseas, according to AP’s account of company disclosures. That gives Unitree a broader commercial base than a robotics company serving only domestic demonstrations, but it also exposes the business to trade controls and market-access risk.
AI-generated editorial illustration. It does not depict a documented real-world event.
Why it matters
The IPO gives public investors direct access to a major Chinese humanoid and quadruped manufacturer. It also places Unitree inside a continuing disclosure regime. Revenue, profit, research spending, product concentration, risks, and related-party arrangements can now be examined through regular filings rather than occasional product launches.
The use of proceeds reveals where the company sees its bottlenecks. The disclosed plan allocates RMB2.022 billion to intelligent robot model research, RMB1.11 billion to robot-body development, RMB445 million to new intelligent robot products, and RMB624 million to a manufacturing base. The largest allocation is therefore aimed at models rather than factory construction alone.
This matters for the wider sector because Unitree’s valuation may become a reference point for other robotics companies seeking public capital. Yet a reference price created during an unusually enthusiastic first trading session is not the same as a stable operating benchmark.
Claims versus evidence
Company claim: Unitree presents itself as a global leader in high-performance general-purpose robots and says its 2025 humanoid shipments ranked first worldwide.
Public evidence: The prospectus provides reported revenue, profitability, product mix, shipment figures, risk disclosures, and planned investment projects. The exchange separately confirms the listing date, ticker, share capital, and tradable share count. Market reporting confirms the offer price, proceeds, and first-day trading range.
Evidence limit: Shipment numbers do not show how many robots perform productive work, how long they operate, or how much service they require. Revenue does not by itself identify recurring customer value. The first-day share price measures investor demand for scarce listed equity; it does not validate robot reliability, general intelligence, or long-term margins.
AI-generated editorial illustration. It does not depict a documented real-world event.
What remains unknown
- How much humanoid revenue comes from research, education, entertainment, development platforms, or sustained industrial use.
- How many shipped robots remain active in customer operations and at what utilization rate.
- Whether humanoid gross margins can remain strong as competition increases and prices fall.
- How quickly the four funded projects will convert IPO capital into products, manufacturing capacity, and repeatable deployment.
- How overseas restrictions will affect Unitree’s ability to sell new models in the United States and other markets.
- Whether the first-day valuation will persist after more operating results become public.
Editorial analysis
The IPO changes Unitree in two concrete ways. It gives the company substantial capital for models, hardware, products, and manufacturing, and it gives outsiders a recurring view into a previously private robotics business. Those changes are more durable than the opening-day price spike.
The listing does not settle whether humanoid robotics has found its dominant commercial use. Unitree has demonstrated that lower-priced, broadly available platforms can generate meaningful sales. The next test is whether growth shifts from developers, education, and demonstrations toward repeatable work with measurable customer returns.
The most useful evidence will come from Unitree’s first public reporting cycles: segment revenue, margin movement, research spending, manufacturing investment, overseas exposure, and any clearer disclosure of deployment quality. Public markets have supplied a dramatic valuation. They now give Unitree the harder obligation to explain what produces it.
Related company, robot, and technology
- Company: Unitree Robotics — publicly listed manufacturer of humanoid and quadruped robots.
- Robot: Unitree G1 — a compact humanoid platform sold for research, development, and application exploration.
- Technology: Humanoid locomotion, whole-body control, embodied-intelligence models, robot components, and scaled manufacturing.
Sources & evidence
- Shanghai Stock Exchange listing announcement for Unitree Robotics — Shanghai Stock Exchange; primary exchange notice; August 18, 2026; accessed September 2, 2026.
- Unitree Robotics IPO prospectus filing — Unitree Robotics via Shanghai Stock Exchange; primary company filing; March 20, 2026; accessed September 2, 2026.
- Unitree Robotics kicks off STAR Market IPO pricing — Shanghai Stock Exchange media page reproducing Global Times reporting and prospectus figures; August 6, 2026; accessed September 2, 2026.
- Shares in Chinese humanoid robot maker Unitree soar in Shanghai debut — Associated Press; independent reporting; August 19, 2026; accessed September 2, 2026.
Sources — Unitree Robotics IPO
Access date for all sources: 2026-09-02
Primary sources
Shanghai Stock Exchange listing announcement
- Publisher: Shanghai Stock Exchange
- URL: https://www.sse.com.cn/disclosure/announcement/listing/ipo/c/c_20260818_10829204.shtml
- Publication date: 2026-08-18
- Source type: Exchange notice; primary
- Supports: Listing venue, listing date, ticker, total A-share capital, and shares initially available for trading.
Unitree Robotics IPO prospectus filing
- Publisher: Unitree Robotics via Shanghai Stock Exchange
- URL: https://static.sse.com.cn/stock/disclosure/announcement/c/202603/002178_20260320_QY8F.pdf
- Publication date: 2026-03-20
- Source type: Company prospectus filing; primary
- Supports: Company history, product scope, business model, reported financial performance, product mix, shipment claims, risk factors, fundraising rationale, and four planned investment projects.
- Evidence caution: This document identifies itself as a filed draft. Company performance and ranking language remains issuer disclosure.
Exchange-hosted context
Unitree Robotics kicks off STAR Market IPO pricing
- Publisher: Shanghai Stock Exchange English site, reproducing Global Times reporting
- URL: https://english.sse.com.cn/news/newsrelease/voice/c/c_20260806_10828128.shtml
- Publication date: 2026-08-06
- Source type: Exchange-hosted media summary based on prospectus and company statement
- Supports: New-share count, planned use-of-proceeds amounts, 2025 revenue, adjusted profit, gross margin, product-mix change, and company-reported humanoid shipments.
Independent source
Shares in Chinese humanoid robot maker Unitree soar in Shanghai debut
- Publisher: Associated Press
- URL: https://apnews.com/article/china-robots-unitree-ipo-shanghai-f33facc61122faf0c0b08af5020bd170
- Publication date: 2026-08-19
- Source type: Independent reporting
- Supports: Offer price, approximate proceeds, first-day opening and closing performance, public-market context, overseas revenue exposure, market-access risk, and distinction between robot shipments and demonstrated productive use.